SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
Abstract Healthcare workers (HCWs) are highly exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this study was to assess the seroprevalence of SARS-CoV-2 in HCWs working in a frontline hospital in Tokyo, Japan. In this observational cohort study, screening was offered to agreed HCWs, including medical, nursing, and others, as part of a mandatory health checkup. The screening test results and clinical characteristics of the participants were recorded. The antibody seroprevalence among the 4,147 participants screened from July 6 to August 21 2020, was 0.34 % (14/4,147). There was no significant difference in seroprevalence between frontline HCWs with a high exposure risk and HCWs in other settings with a low exposure risk. Of those seropositive for SARS-CoV-2, 64% (9/14) were not aware of any symptoms and had not previously been diagnosed with COVID-19. In conclusion, this study provides insights into the extent of infection and immune status in HCWs in Japan, which has a relatively low prevalence of COVID-19..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
ResearchSquare.com - (2022) vom: 29. Juli Zur Gesamtaufnahme - year:2022 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
FUKUDA, Hiroshi [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
doi: |
10.21203/rs.3.rs-96870/v1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XRA034765743 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XRA034765743 | ||
003 | DE-627 | ||
005 | 20230429193651.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220113s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21203/rs.3.rs-96870/v1 |2 doi | |
035 | |a (DE-627)XRA034765743 | ||
035 | |a (ResearchSquare)10.21203/rs.3.rs-96870/v1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a FUKUDA, Hiroshi |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Healthcare workers (HCWs) are highly exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this study was to assess the seroprevalence of SARS-CoV-2 in HCWs working in a frontline hospital in Tokyo, Japan. In this observational cohort study, screening was offered to agreed HCWs, including medical, nursing, and others, as part of a mandatory health checkup. The screening test results and clinical characteristics of the participants were recorded. The antibody seroprevalence among the 4,147 participants screened from July 6 to August 21 2020, was 0.34 % (14/4,147). There was no significant difference in seroprevalence between frontline HCWs with a high exposure risk and HCWs in other settings with a low exposure risk. Of those seropositive for SARS-CoV-2, 64% (9/14) were not aware of any symptoms and had not previously been diagnosed with COVID-19. In conclusion, this study provides insights into the extent of infection and immune status in HCWs in Japan, which has a relatively low prevalence of COVID-19. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a SEYAMA, Kuniaki |e verfasserin |4 aut | |
700 | 1 | |a ITO, Kanami |e verfasserin |4 aut | |
700 | 1 | |a HORI, Satoshi |e verfasserin |4 aut | |
700 | 1 | |a WAKITA, Mitsuru |e verfasserin |4 aut | |
700 | 1 | |a SAITO, Kaori |e verfasserin |4 aut | |
700 | 1 | |a SHIDA, Yuka |e verfasserin |4 aut | |
700 | 1 | |a NAGURA, Rie |e verfasserin |4 aut | |
700 | 1 | |a HASEGAWA, Mayu |e verfasserin |4 aut | |
700 | 1 | |a KANEMOTO, Chiaki |e verfasserin |4 aut | |
700 | 1 | |a TOKUHARA, Mayumi |e verfasserin |4 aut | |
700 | 1 | |a OKAJIMA, Katsunobu |e verfasserin |4 aut | |
700 | 1 | |a YOSHIKAWA, Yukio |e verfasserin |4 aut | |
700 | 1 | |a KATSUTA, Narimasa |e verfasserin |4 aut | |
700 | 1 | |a YAMAMOTO, Takamasa |e verfasserin |4 aut | |
700 | 1 | |a AI, Tomohiko |e verfasserin |4 aut | |
700 | 1 | |a IDEI, Mayumi |e verfasserin |4 aut | |
700 | 1 | |a MISAWA, Shigeki |e verfasserin |4 aut | |
700 | 1 | |a NAITO, Toshio |e verfasserin |4 aut | |
700 | 1 | |a MIIDA, Takashi |e verfasserin |4 aut | |
700 | 1 | |a SATO, Hiroyuki |e verfasserin |4 aut | |
700 | 1 | |a HATTORI, Nobutaka |e verfasserin |4 aut | |
700 | 1 | |a TABE, Yoko |e verfasserin |4 aut | |
700 | 1 | |a TAKAHASHI, Kazuhisa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2022) vom: 29. Juli |
773 | 1 | 8 | |g year:2022 |g day:29 |g month:07 |
856 | 4 | 0 | |u https://doi.org/10.1038/s41598-021-87688-9 |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-96870/v1 |z kostenfrei |3 Volltext |
912 | |a GBV_XRA | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2022 |b 29 |c 07 |